Medical-device makers ResMed and Inspire slump after Lilly’s Zepbound trial shows benefits for sleep apnea Jun. 24, 2024 at 11:26 a.m. ET by Ciara Linnane Inspire Medical Systems downgraded to hold from buy at Stifel Jan. 2, 2024 at 7:00 a.m. ET by Tomi Kilgore Inspire Medi...
2014. As the only FDA-approved implantable device for obstructive sleep apnea patients who don’t get benefit from traditional CPAP therapy, the company also noted that over